Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

ENDRA Life Sciences (NDRA) Return on Sales (2016 - 2018)

ENDRA Life Sciences has reported Return on Sales over the past 3 years, most recently at 15.87% for Q4 2018.

  • Quarterly Return on Sales fell 1252.0% to 15.87% in Q4 2018 from the year-ago period, while the trailing twelve-month figure was 15.87% through Dec 2018, down 1571.0% year-over-year, with the annual reading at 15.87% for FY2018, 1571.0% down from the prior year.
  • Return on Sales was 15.87% for Q4 2018 at ENDRA Life Sciences, down from 7.47% in the prior quarter.
  • Over five years, Return on Sales peaked at 0.01% in Q4 2016 and troughed at 15.87% in Q4 2018.
  • The 3-year median for Return on Sales is 1.81% (2018), against an average of 3.98%.
  • The largest YoY upside for Return on Sales was -1bps in 2018 against a maximum downside of -1252bps in 2018.
  • A 3-year view of Return on Sales shows it stood at 0.01% in 2016, then tumbled by -24971bps to 3.35% in 2017, then tumbled by -374bps to 15.87% in 2018.
  • Per Business Quant, the three most recent readings for NDRA's Return on Sales are 15.87% (Q4 2018), 7.47% (Q3 2018), and 0.26% (Q2 2018).